Immunopeptidomic Profiling of HLA‐A2‐Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens

The recent development in immune checkpoint inhibitors and chimeric antigen receptor (CAR) T‐cells in the treatment of cancer has not only demonstrated the potency of utilizing T‐cell reactivity for cancer therapy, but has also highlighted the need for developing new approaches to discover targets s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Proteomics
Main Authors: Ternette, Nicola, Olde Nordkamp, Marloes J. M., Müller, Julius, Anderson, Amanda P., Nicastri, Annalisa, Hill, Adrian V. S., Kessler, Benedikt M., Li, Demin
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6032843/
https://ncbi.nlm.nih.gov/pubmed/29786170
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pmic.201700465
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados